Increasing treatment enrollment among smokers who are not motivated to quit: a randomized clinical trial.
Transl Behav Med
; 12(1)2022 01 18.
Article
en En
| MEDLINE
| ID: mdl-34424337
ABSTRACT
There is a significant research-to-practice gap with respect to reaching underserved populations with evidence-based tobacco cessation treatments. Increasing enrollment in evidence-based treatments is necessary to reduce tobacco use and tobacco-related health inequities. The purpose of the current study was to evaluate whether Motivation And Problem Solving (MAPS), a flexible, holistic counseling/navigation approach delivered via phone, and proactive provision of Nicotine Replacement Therapy (NRT) would improve Quitline enrollment among a sample of low SES smokers who were not motivated to quit. In a 3×2 factorial design, cigarette smokers (N = 603) were randomized to one of six treatment conditions (Standard Treatment, MAPS-6, or MAPS-12 by NRT or no NRT). Results indicated that both MAPS-6 and MAPS-12 increased Quitline enrollment compared to Standard Treatment (ps < .03). There were no differences between MAPS conditions. NRT did not increase Quitline enrollment. MAPS is an effective intervention with the potential to be disseminated and implemented in healthcare and community settings to increase the reach of evidence-based interventions for tobacco cessation.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Cese del Hábito de Fumar
/
Fumadores
Tipo de estudio:
Clinical_trials
Idioma:
En
Revista:
Transl Behav Med
Año:
2022
Tipo del documento:
Article
País de afiliación:
Estados Unidos